The combination of afatinib with dasatinib or miransertib results in synergistic growth inhibition of stomach cancer cells

Research output: Contribution to journal › Article › peer-review

Keywords

@article{fef951f8e2ed4ac080ae3026e6500199,

title = "The combination of afatinib with dasatinib or miransertib results in synergistic growth inhibition of stomach cancer cells",

keywords = "Cancer studies",

author = "Tina Al-Janaby and Narmin Nahi and Alan Seddon and Izhar Bagwan and Said Khelwatty and Helmout Modjtahedi",

year = "2024",

month = apr,

doi = "10.14740/wjon1769",

language = "English",

volume = "15",

pages = "192--208",

journal = "World Journal of Oncology",

issn = "1920-4531",

publisher = "Elmer Press",

number = "2",

}

TY - JOUR

T1 - The combination of afatinib with dasatinib or miransertib results in synergistic growth inhibition of stomach cancer cells

AU - Al-Janaby, Tina

AU - Nahi, Narmin

AU - Seddon, Alan

AU - Bagwan, Izhar

AU - Khelwatty, Said

AU - Modjtahedi, Helmout

PY - 2024/4

Y1 - 2024/4

KW - Cancer studies

U2 - 10.14740/wjon1769

DO - 10.14740/wjon1769

M3 - Article

SN - 1920-4531

VL - 15

SP - 192

EP - 208

JO - World Journal of Oncology

JF - World Journal of Oncology

IS - 2

ER -